They have also shown that the incretin effect is reduced in humans living with type-2-diabetes (152), and that this is due to loss of GIP’s (153, 154), but not GLP-1’s, insulinotropic activity (155–157). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.